Skip to main content
Premium Trial:

Request an Annual Quote

Ventana and BD Biosciences to Co-Market DNA Microarrays and Analysis System

NEW YORK, July 11 – Ventana Medical Systems and BD Biosciences Clontech Laboratories have agreed to non-exclusively co-market their microarray products, the companies said Wednesday.

Together, the two companies will co-promote BD Biosciences’ DNA microarrays, and Ventana’s microarray analysis platform. Financial details of the deal were not disclosed.

BD Biosciences Clontech, based in Palo Alto, Calif, manufactures pre-spotted glass microarrays containing up to 3800 human, mouse, and rat DNA oligonucleotides. Ventana’s microarray analysis system automates slide staining for hybridizing DNA microarrays in gene expression and other experiments. 

Ventana, based in Tucson, Ariz., has partnered with Genicon Sciences to develop its microarray analysis system.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.